Caption Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-100,200
| Closed | -$13.2M | – | 2011 |
|
|
2025
Q1 | $13.2M | Buy |
+100,200
| New | +$12.5M | 0.13% | 146 |
|
|
2024
Q3 | – | Sell |
-60,000
| Closed | -$4.11M | – | 1655 |
|
|
2024
Q2 | $4.11M | Sell |
60,000
-430,900
| -88% | -$29.9M | 0.06% | 305 |
|
|
2024
Q1 | $34M | Buy |
490,900
+460,900
| +1,536% | +$31.7M | 0.52% | 36 |
|
|
2023
Q4 | $2.15M | Sell |
30,000
-25,000
| -45% | -$1.44M | 0.03% | 597 |
|
|
2023
Q3 | $2.86M | Buy |
55,000
+40,000
| +267% | +$2.33M | 0.04% | 488 |
|
|
2023
Q2 | $950K | Sell |
15,000
-15,000
| -50% | -$935K | 0.02% | 674 |
|
|
2023
Q1 | $1.62M | Buy |
30,000
+12,900
| +75% | +$624K | 0.03% | 506 |
|
|
2022
Q4 | $905K | Hold |
17,100
| – | – | 0.01% | 780 |
|
|
2022
Q3 | $796K | Sell |
17,100
-60,000
| -78% | -$3.13M | 0.01% | 939 |
|
|
2022
Q2 | $4.4M | Buy |
+77,100
| New | +$4.37M | 0.06% | 398 |
|
|
2022
Q1 | – | Sell |
-187,200
| Closed | -$9.8M | – | 2049 |
|
|
2021
Q4 | $9.8M | Buy |
+187,200
| New | +$7.86M | 0.11% | 240 |
|
|
2021
Q2 | – | Sell |
-34,700
| Closed | -$1.18M | – | 1626 |
|
|
2021
Q1 | $1.18M | Buy |
+34,700
| New | +$1.2M | 0.03% | 648 |
|
|
2020
Q3 | – | Sell |
-321,800
| Closed | -$8.26M | – | 1315 |
|
|
2020
Q2 | $8.26M | Buy |
+321,800
| New | +$6.51M | 0.28% | 85 |
|
|
2020
Q1 | – | Sell |
-1,393,000
| Closed | -$47.8M | – | 1123 |
|
|
2019
Q4 | $47.8M | Buy |
1,393,000
+854,000
| +158% | +$10.2M | 1.61% | 3 |
|
|
2019
Q3 | $4.03M | Buy |
539,000
+436,700
| +427% | +$4.19M | 0.21% | 130 |
|
|
2019
Q2 | $1.33M | Buy |
102,300
+62,300
| +156% | +$799K | 0.07% | 319 |
|
|
2019
Q1 | $488K | Buy |
+40,000
| New | +$511K | 0.03% | 440 |
|
Other funds holding ITCI
KIM
HNB